Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns naming Kevin Barrett .
Filed returns
14
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2024 | BioMarin International Limited | Health | Rare disease policy and access to treatments in Ireland and EU (Legislation) | 29 | On lobbying.ie |
| Sep–Dec 2023 | BioMarin International Limited | Health | Rare disease policy in Ireland and the EU (Legislation) | 43 | On lobbying.ie |
| Sep–Dec 2023 | Pfizer | Health | Ireland's medicine reimbursement system and Budget funding for new medicines (Matters involving public funds) | 9 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | Continued importance of a competitive and favorable business environment in Ireland (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2023 | Vulcan Consulting Limited | Health | Strategic Operations in Ireland & Medicines Policy (Public policy or programme) | 9 | On lobbying.ie |
| May–Aug 2023 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Update on AstraZeneca operations in Ireland (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2023 | MSD | Health | Access to innovative cancer medicines (Public policy or programme) | 7 | On lobbying.ie |
| Jan–Apr 2023 | BioMarin International Limited | Health | Rare Disease Policy in Ireland (Legislation) | 39 | On lobbying.ie |
| Jan–Apr 2023 | Pfizer | Health | Ireland's pricing and reimbursement system and funding for new medicines (Public policy or programme) | 14 | On lobbying.ie |
| Sep–Dec 2022 | BioMarin International Limited | Health | Rare Disease Policy in Ireland (Legislation) | 13 | On lobbying.ie |
| Sep–Dec 2022 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2022 | Gerard Howlin | Health | To seek support for legislative change for mental health, for greater public investment in Budget 2023 and for policy change to deliver better services. (Matters involving public funds) | 5 | On lobbying.ie |
| Jan–Apr 2021 | MSD | Health | Oncology Policy (Public policy or programme) | 9 | On lobbying.ie |
| Jan–Apr 2021 | Irish Pharmaceutical Healthcare Association | Health | Extension of framework agreement on medicines. (Public policy or programme) | 14 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 14 | 100.0% |